Piramal Pharma (PPLPHARMA.NSE) Q2 2026 Earnings

28AprConfirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-0.81
-0.22
0.38
0.97

Details

Expected EPS
0.9715625582399999
Actual EPS
0.91083989835
Surprise EPS
-0.06
Surprise Percent
+6.25%

Description

Piramal Pharma (PPLPHARMA.NSE) has reported earnings of 0.91083989835 per share for Q2 2026.

0 Comments

Share your thoughts